ICAM1 and infection: More recently, SCMC has been proven to modulate airways inflammation caused by rhinovirus [13], respiratory syncytial virus, and type A seasonal influenza virus [14] infections by decreasing the expression of intercellular adhesion molecule-1 (ICAM-1), which is the receptor for the major respiratory pathogens.